EyePoint (EYPT) Return on Capital Employed Growth (3y) (2014 - 2026)
EyePoint (EYPT) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | -3,782.00 |
| 10 | EyePoint | 1.10 Mn | -221.44 Mn | 168,000.00 | -2,426.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,426.00 |
| Dec 31, 2025 | -2,983.00 |
| Sep 30, 2025 | -5,026.00 |
| Jun 30, 2025 | -2,883.00 |
| Mar 31, 2025 | -1,805.00 |
| Dec 31, 2024 | -1,819.00 |
| Sep 30, 2024 | -1,181.00 |
| Jun 30, 2024 | -1,531.00 |
| Mar 31, 2024 | -186.00 |
| Dec 31, 2023 | 1,513.00 |
| Sep 30, 2023 | -4,294.00 |
| Jun 30, 2023 | -4,086.00 |
| Mar 31, 2023 | -606.00 |
| Dec 31, 2022 | 1,414.00 |
| Sep 30, 2022 | 4,640.00 |
| Jun 30, 2022 | 6,753.00 |
| Mar 31, 2022 | 11,936.00 |
| Dec 31, 2021 | 8,680.00 |
| Sep 30, 2021 | 5,903.00 |
| Jun 30, 2021 | 5,690.00 |